Thursday, January 20, 2022
Home News South Africa to Produce Over 100 Million Pfizer Vaccines A Year

South Africa to Produce Over 100 Million Pfizer Vaccines A Year

Pharmaceutical heavyweights Pfizer and BioNTech have agreed to partner with South Africa’s Biovac Institute to produce their COVID-19 vaccines at a facility in Cape Town.

First announced on Wednesday, this deal will see more than 100-million doses of Pfizer’s COVID-19 vaccines produced annually to be distributed to African nations.

Biovac had previously worked with Pfizer to produce its Prevnar 13 vaccine, a vaccine designed to protect against pneumococcal bacteria that most commonly causes serious infections in children and adults. Now, Biovac is expected to manufacture and distribute vaccines to Pfizer and BioNTech supply chains globally, according to Fin24.

The doses manufactured by Biovac will go to the African Union’s 55 member states.

According to a joint statement, Pfizer and BioNTech expect Biovac’s Cape Town facility to begin incorporation into the vaccine supply chain by the end of 2021.

Biovac is set to obtain the pre-vaccine drug material and substances from facilities in Europe. Manufacturing of finished doses of the COVID-19 vaccine will begin in 2022.

“From day one, our goal has been to provide fair and equitable access of the Pfizer-BioNTech COVID-19 vaccine to everyone, everywhere,” said Albert Bourla, chairperson and CEO of Pfizer, quoted by Fin24.

“Our latest collaboration with Biovac is a shining example of the tireless work being done, in this instance to benefit Africa.”

“We will continue to explore and pursue opportunities to bring new partners into our supply chain network, including in Latin America, to further accelerate the access of COVID-19 vaccines,” Bourla said.

“We aim to enable people on all continents to manufacture and distribute our vaccine while ensuring the quality of the manufacturing process and the doses,” said Ugur Sahin, MD, CEO and co-founder of BioNTech.

“We believe that our mRNA technology can be used to develop vaccine candidates addressing other diseases as well. This is why we will continue to evaluate sustainable approaches that will support the development and production of mRNA vaccines on the African continent.”


Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Crown Flour Mills – Largest Milling Operation in Africa and 10th largest in the world

Crown Flour Mill has been in the wheat milling business in Nigeria for over four decades. Incorporated...

Africa’s Top LinkedIn Influencers 2021

The Tech Times Africa Top LinkedIn Influencer Award is Africa’s largest and most prestigious accolades for the most influential personalities in the...

Nigeria lifts ban on Twitter, says the social media giant has met conditions

The Nigerian government has lifted the suspension of Twitter operations more than six months after it first declared a...

How Touch and Pay (TAP) got 1.5 million Lagosians to adopt cashless bus rides

It was a busy Thursday afternoon in one of Nigeria’s busiest cities — Lagos. Three young men...

Recent Comments

Obunseh patrick chukwuma. on Vote: Africa Corporate Brands Awards, 2020
Egbe Anyalewechi Malvin on Vote: Africa Corporate Brands Awards, 2020
Egbe Anyalewechi Malvin on Vote: Africa Corporate Brands Awards, 2020
DON'T FALL BEHINDBe The First To Get Notified on the latest Articles on Tech Times Africa. FREE!

Join over 940,000 subscribers worldwide. Receive our newsletter daily and straight into your inbox.